Chris Farkas
Analyst · Baird
Okay. Thank you, Lynn. I’ll begin with the key drivers of our fourth quarter 2022 results by segment. In Aerospace & Industrial, sales increased 8% overall, or more than 10% on an organic basis, but excluding the impact of FX. Within the segments Commercial Aerospace market, our results reflected continued strong demand on both narrowbody and widebody platforms. In the General Industrial market, our results reflected double-digit sales growth driven by higher sales of Industrial Vehicle Products and Surface Treatment Services. And those increases were partially offset by reduced sales in the segments Aerospace Defense market due to the timing of production on various programs. Regarding the segments’ profitability, our results reflect favorable absorption on higher organic sales as well as some unfavorable mix on products and services which impact that operating margin. Next in the Defense Electronics segment, despite the ongoing supply chain challenges, we concluded the year with a strong fourth quarter performance. Sales growth of 18% reflected higher revenues for Embedded Computing Equipment on various Fighter Jet and Helicopter programs in Aerospace Defense, as well as increased sales of Tactical Communications Equipment in Ground Defense. Turning to the segments’ operating performance, adjusted operating income increased 33%, while adjusted operating margin increased 320 basis points to 29.7%, reflecting strong absorption on higher A&D revenues. Next in the Naval & Power segment, sales growth of 20% was driven by high single-digit organic growth, as well as the contribution from our Arresting Systems business. In the Naval Defense market, higher revenues principally reflected the ramp up on the Columbia-class submarine program. However, our results were about $10 million lower than expected primarily due to the timing of revenues on the CVN-81 aircraft carrier program which shifted into 2023. In the Power & Process market are results reflected strong demand in the Nuclear Aftermarket supporting the operation of existing reactors, increased revenue supporting Gen 4 advanced reactors and higher valve sales in Process. These increases more than offset the wind down of production on the CAP1000 program in the fourth quarter, and of note, on a full year basis, CAP1000 program revenues decreased $25 million in 2022, and we expect to recognize the remaining $5 million in revenues on this program in 2023. Regarding the segments’ fourth quarter profitability, our results reflected favorable absorption on higher organic sales and the benefits of our prior year restructuring initiatives in addition to a strong performance from our Arresting Systems business. To sum up the fourth quarter results overall, we generated strong double-digit growth in sales, and 140 basis points in year-over-year operating margin expansion, highlighting the strength of our combined portfolio and a solid finish to 2022. Next, turning to our full year ‘23 guidance, I’ll begin on Slide 5 of their end market sales outlook, where we expect organic sales to grow 3% to 5% in line with our long-term guidance, and we’re projecting total sales growth of 4% to 6%, which includes the contribution from the Arresting Systems Acquisition, partially offset by a small headwind from FX. I’ll start with A&D markets, where sales are expected to increase 6% to 8%. In Aerospace Defense, growth of 9% to 11% reflects the contribution from our Arresting Systems business, as well as in mid-single-digit organic growth for Defense Electronics on various Fighter Jet programs, which will be partially offset by lower actuation revenues within the A&I segment. In Ground Defense, we expect growth of 4% to 6%, reflecting higher revenues for Tactical Battlefield Communication Systems, as well as increased international sales of our Turret Stabilization Systems. Next, in Naval Defense, our outlook for 4% to 6% sales growth principally reflects higher revenues, driven by the strong ramp up in production on both the Columbia-class submarine and the CVN-81 aircraft carrier programs. That wrap up our A&D markets and turning to Commercial Aerospace, our outlook for 5% to 7% sales growth is driven by higher OEM production rates on narrowbody aircraft including the 737 and A320 and widebody aircraft including the 787 and A350. Our guidance in this market also includes a 2% headwind from FX. Turning now to our Commercial Markets, where we expect overall sales to be flat to up 2%. In Power & Process, we’re expecting flat growth overall. However, this outlook includes a revenue headwind from the CAP1000 program of approximately $20 million. Excluding that impact, we expect mid-single-digit growth in the Commercial Nuclear market. This reflects solid demand for ongoing maintenance and subsequent license renewals that extend the life of existing nuclear power generation fleet, as well as increased sales supporting Gen 4 advanced reactors, most notably tied to our recent agreement with X-energy. We also expect mid-single-digit growth in the Process market, reflecting higher development revenues, supporting ongoing subsea pumping initiatives, and continued solid MRO demand for our valves. Lastly, in the General Industrial market, we expect growth of 2% to 4%, including a 1% headwind from FX, driven by higher sales of Industrial Vehicle Products and Surface Treatment Services. As we look at the combined total Commercial market, it’s important to note that excluding the wind down on the CAP1000 program, overall commercial sales growth would be of 3% to 5%. Continuing with our full year outlook by segment on Slide 6. I’ll begin in Aerospace & Industrial, where we expect sales to grow 1% to 3%, including a $10 million or 1% headwind from FX. Our outlook for this segment is driven by solid growth in both Commercial Aerospace and General Industrial, partially offset by the timing of sales and defense. We expect adjusted operating income growth of 4% to 7% and adjusted operating margin expansion of 50 to 70 basis points to a range of 17.0% to 17.2%, reflecting higher sales, and the continued benefits of our prior restructuring initiatives. Next, in Defense Electronics, we expect sales to grow 5% to 9%, principally driven by this business’s record 2022 order book and cautious expectations for improved supply chain stability. We expect adjusted operating income growth of 7% to 11% and adjusted operating margin expansion of 30 to 50 basis points to a range of 22.7% to 22.9% based upon the strong revenue growth. And lastly in the Naval & Power segment, we expect sales to grow 5% to 7%, driven by solid growth in Naval Defense, mid-single-digit growth in both the Commercial Nuclear and Process markets and the contribution from our Arresting Systems acquisition. Operating income is projected to be essentially flat, while our operating margin is expected to range from 17.5% to 17.7%, reflecting both negative mix on lower CAP1000 revenues, and a shift to lower margin development contracts in the Power & Process market. Excluding those items, operating margin in the segment will be nearly flat year-over-year. So to summarize our outlook, we expect total Curtiss-Wright operating income growth of 5% to 8% overall, in excess of sales growth, and expect operating margin to improve 10 to 30 basis points ranging from 17.4% to 17.6%. And I’m pleased to note, that we continue to deliver operating margin expansion as we maintain our strategic focus on investments. Our outlook for 2023 includes a year-over-year increase of more than $20 million in total research and development investments, including both contract and our A&D programs. Continuing with our 2023 financial outlook on Slide 7, I wanted to provide some color on a few non-operational items, and I’ll start with our pension plan. 2022 was a difficult year for most pension plan sponsors as returns were weak across nearly all asset classes. However, the Fed’s aggressive interest rate hikes and the resulting impact on pension discount rates helped to mitigate the impact of the short-term negative asset returns and resulted in a minimal impact on our funded status. In fact, our funded status percentage increased year-over-year. In early 2022, we also took steps to protect the funded status of the plan by implementing a glide path investment strategy that de-risks the plan, and by increasing our fixed income allocation to more closely match plan liabilities as the funded status improves. Our goal is to reduce volatility as the plan approaches the sunset of accruals. As a result, we are now expecting a tailwind of approximately $10 million in other income for 2023. And more importantly, we do not expect to make any cash contributions to the planned sunset date in 2028. Next, we anticipate higher interest expense in 2023, primarily due to rising interest rates and the impact of our revolver which represents a headwind of approximately $6 million or $0.12 compared with 2022. And lastly, our tax rate in 2023 is expected to be unchanged as we enter the year at approximately 24%. Turning to our EPS guidance, we expect full year 2023 adjusted diluted EPS to range from $8.65 to $8.90, up 6% to 10%, mainly reflecting our strong growth in operating income and an approximate 1% to 2% benefit from the below the line items. To aid in your quarterly modeling, we expect our 2023 quarterly EPS to follow a similar cadence to last year, with the first quarter expected to be our lightest, but reflecting mid-single-digit growth relative to our prior year first quarter adjusted EPS. For the remainder of 2023, we expect sequential quarterly improvement with the fourth quarter being our strongest, including approximately 40% of our full year earnings per share in the first half. Lastly, turning to our free cash flow guidance. We’re projecting full year adjusted free cash flow of $360 million to $400 million, up 22% to 36%. Our outlook is driven by expectations for higher cash earnings and improvements in working capital as we burn down through our excess inventory and continue to accelerate our cash collections, particularly for those businesses most impacted by the supply chain disruption. Our guidance also includes the collection of the remaining $20 million CAP1000 cash payment which we expect to receive upon final delivery of our reactor coolant pumps to China. Of note, we’re targeting this cash flow as we invest to support our future growth, and while also facing a $25 million headwind related to the section 174 R&D tax amortization. Based on these changes, our full year 2023 free cash flow conversion rate is expected to exceed 110% based upon the midpoint of our guidance. And now, I’d like to turn the call back over to Lynn to continue with our prepared remarks. Lynn?